Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphocytic Bronchiolitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Not applicableStudy completedNCT02461316
What this trial is testing

Rituximab in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Lymphocytic Leukemia, Chronic, Chronic Lymphocytic Leukemia, Cancer
Hoffmann-La Roche 22
Early research (Phase 1)Study completedNCT00742144
What this trial is testing

Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
Leukaemia, Lymphocytic, Chronic and Lymphoma, Follicular
GlaxoSmithKline 6
Early research (Phase 1)Study completedNCT00825487
What this trial is testing

Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies

Who this might be right for
Metastatic Solid Tumors, Refractory/Relapsed Hematologic Malignancies
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 50
Not applicableUnknownNCT04372524
What this trial is testing

Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study

Who this might be right for
Chronic Graft-versus-Host-DiseaseLeukemiaAllogeneic Hematopoietic Stem Cell Transplantation+2 more
University of British Columbia 350
Testing effectiveness (Phase 2)Ended earlyNCT01600053
What this trial is testing

Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Thomas Kipps 11
Early research (Phase 1)Study completedNCT01991184
What this trial is testing

GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

Who this might be right for
Lymphocytic Leukemia, Chronic, Diffuse Large B-Cell Lymphoma
Genentech, Inc. 24
Early research (Phase 1)Study completedNCT00457782
What this trial is testing

A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Multiple MyelomaChronic Lymphocytic LeukaemiaB-cell Non-Hodgkin's Lymphoma
Kyowa Kirin Co., Ltd. 27
Not applicableTemporarily pausedNCT04843345
What this trial is testing

Sjogren's Lung Study

Who this might be right for
Sjogren's SyndromeInterstitial Lung DiseasePrimary Pulmonary Lymphoma (Disorder)+5 more
Stanford University 500
Testing effectiveness (Phase 2)Study completedNCT00078234
What this trial is testing

Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Genta Incorporated 25
Early research (Phase 1)WithdrawnNCT02743546
What this trial is testing

Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular+1 more
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)UnknownNCT00800943
What this trial is testing

Study of Subcutaneous Campath-1H in Patients With B-Cell CLL and Residual Disease After Chemotherapy

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia Research Consortium 31
Testing effectiveness (Phase 2)Study completedNCT02388048
What this trial is testing

Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia, Lymphoblastic, Chronic
Gruppo Italiano Malattie EMatologiche dell'Adulto 19
Testing effectiveness (Phase 2)Study completedNCT00328198
What this trial is testing

Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Genzyme, a Sanofi Company 86
Early research (Phase 1)Temporarily pausedNCT05993611
What this trial is testing

Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Chronic Graft Versus Host DiseaseHematologic and Lymphocytic DisorderSteroid Refractory Graft Versus Host Disease
City of Hope Medical Center 27